Dr. Fareed A. Cheema, MD

Dr. Cheema practices at Nyu Langone Hospital-Brooklyn-Cardiac Catheterization Lab - HOPD in Brooklyn, New York.

Dr. Cheema's NPI, 1629431101, was assigned on April 1, 2016. Dr. Cheema graduated from Drexel University College of Medicine in 2016. Dr. Cheema holds New York license 308434.

Dr. Cheema's primary practice is Nyu Langone Hospital-Brooklyn-Cardiac Catheterization Lab - HOPD, at 150 55th St, Brooklyn, NY 11220.

Dr. Cheema's primary practice is Nyu Langone Hospital-Brooklyn-Cardiac Catheterization Lab - HOPD in Brooklyn, New York. Dr. Cheema is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Cheema to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Cheema's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheema practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Cheema's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Cheema is licensed in New York.

CMS data shows 95 Medicare services from Dr. Cheema across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $5,161 for them. Every service was in an office.

CMS counts 78 Medicare patients who saw Dr. Cheema in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheema's median patient age at 53, with 59% women.

In 2024, Dr. Cheema wrote 330 Medicare Part D claims for 83 patients. 82% of them were for generic drugs. CMS names the drug for 186 of them, across 10 drugs with 11 or more claims each, at $52,762 in total drug cost. In 2023, CMS named 49 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Cheema for performance year 2024, reported as part of a group. Dr. Cheema accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheema as offering telehealth. CMS counts 14 procedures of hernia repair (minimally invasive) by Dr. Cheema, more than 80% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Cheema, published from 2020 to 2025. The most frequent topics are Gastrectomy, Herniorrhaphy and Incisional Hernia. Dr. Cheema has published most often in Surg Endosc. Dr. Cheema's most frequent co-authors are Oya Munevver Andacoglu, MD, Edward Chao, MD and Jenny Jee-Eun Choi, MD.

CMS Open Payments shows 75 general payments to Dr. Cheema from 15 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 52% of the total. Medtronic, Inc. paid the most, $2,096.

Dr. Cheema graduated from Drexel University College of Medicine in 2016.